These data were supported by further analysis of the TCGA COAD data, which demonstrated a substantial decrease in mRNA expression of HSD17B2, and increased expression of HSD17B7 and HSD17B12, in colon cancer (Supplemental Fig. 1). Here, HSD17B2 is linked to malignant colon neoplasm.